Patents by Inventor Russell M. Hagan

Russell M. Hagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5547964
    Abstract: The present invention relates to the use of certain tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis.
    Type: Grant
    Filed: March 17, 1994
    Date of Patent: August 20, 1996
    Assignee: Glaxo Group Limited
    Inventors: Russell M. Hagan, Keith T. Bunce
  • Patent number: 5538982
    Abstract: The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel tachykinin antagonists of formula (I), processes for their preparation, pharmaceutical compositions containing them and their medical use. ##STR1## wherein R represents the ring A ##STR2## or 2-pyridinyl or 2-pyridinyl-N-oxide; R.sup.1 is selected from halogen atoms and C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl, and S(O).sub.n C.sub.1-4 alkyl groups;R.sup.2 and R.sup.3, which may be the same or different, each independently are selected from hydrogen and halogen atoms and C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl and cyano groups;n represents zero, 1 or 2;and pharmaceutically acceptable salts and solvates thereof.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: July 23, 1996
    Assignee: Glaxo Group Limited
    Inventors: Russell M. Hagan, Keith T. Bunce
  • Patent number: 5360820
    Abstract: The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel tachykinin antagonists of formula (I), processes for their preparation, pharmaceutical compositions containing them and their medical use. ##STR1## wherein R represents the ring A ##STR2## or 2-pyridinyl or 2-pyridinyl-N-oxide; R.sup.1 is selected from halogen atoms and C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl, and S(O).sub.n C.sub.1-4 alkyl groups;R.sup.2 and R.sup.3, which may be the same or different, each independently are selected from hydrogen and halogen atoms and C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl and cyano groups;n represents zero, 1 or 2;and pharmaceutically acceptable salts and solvates thereof.
    Type: Grant
    Filed: September 18, 1992
    Date of Patent: November 1, 1994
    Assignee: Glaxo Group Limited
    Inventors: Russell M. Hagan, Keith T. Bunce, Alan Naylor, Mark Ladlow, Andrew B. McElroy, Andrew R. Whittington, Barry A. Coomber
  • Patent number: 4506519
    Abstract: A hermetic compressor discharge line thermal block is hermetically coupled in the discharge line between a condenser and compressor adjacent to the discharge outlet of the compressor. The device is formed to define a well for removably receiving a heating element, and has a hermetically sealed chamber substantially surrounding the heater well and electric heating element. Upon compressor shutdown, liquid refrigerant migrating from the condenser partially fills the chamber, thereby decreasing the temperature of the heating element below a predetermined temperature, thereby causing the heating element to become electrically conductive to supply heat to the chamber to evaporate the liquid refrigerant therein and to prevent further accumulation of liquid.
    Type: Grant
    Filed: August 24, 1983
    Date of Patent: March 26, 1985
    Assignee: Tecumseh Products Company
    Inventors: Robert L. Morse, Russell M. Hagan